share_log

JP Morgan Maintains Overweight on Akoya Biosciences, Lowers Price Target to $10

Moomoo 24/7 ·  Mar 6 11:06

JP Morgan analyst Tycho Peterson maintains Akoya Biosciences (NASDAQ:AKYA) with a Overweight and lowers the price target from $12 to $10.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment